Medical Devices Startups

Cooler Heads develops scalp cooling technology to prevent hair loss in cancer patients undergoing chemotherapy. The company manufactures the Amma scalp cooling system for oncology clinics and hospitals.

14 investors

Mammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.

14 investors

Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry. The company targets an unmet clinical need where no approved therapeutic options currently exist.

13 investors

Dandy is a digital dental laboratory that provides AI-powered technology and software to dental practices, offering services including crowns, bridges, dentures, implants, and clear aligners. The company serves dentists and dental practices with digital workflows, intraoral scanners, and case management tools to enhance clinical accuracy and patient outcomes.

13 investors

Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models. The company aims to address the global shortage of liver transplants by developing new treatment options for liver fibrosis and cirrhosis.

13 investors

Orange Health Labs operates a home-based diagnostic testing service in Indian cities, offering sample collection within 30 minutes and lab results within 6 hours. The company serves urban consumers seeking rapid medical testing across major metropolitan areas.

13 investors

Proscia provides a digital pathology software platform that converts glass microscope slides into high-resolution digital images for viewing, management, and analysis by pathologists and research teams. The platform enables clinical laboratories and life sciences organizations to improve workflow efficiency, support remote collaboration, and integrate artificial intelligence tools for quantitative tissue analysis and biomarker detection.

13 investors

Senti Bio develops cell and gene therapies for cancer and difficult-to-treat diseases using synthetic biology and engineered Gene Circuits to enhance precision, control, and selectivity in targeting tumor cells. The company is a clinical-stage biotech firm leveraging proprietary platform technology across multiple cell types and modalities.

13 investors

Siren develops technology for early detection of diabetic foot ulcers to reduce injury risk. The company serves healthcare providers and patients managing diabetes.

13 investors

SelfWrap develops bioabsorbable wrap materials for vascular grafts that conform to individual patient anatomy and are designed to be absorbed by the body, unlike alloy-based alternatives. The company is developing the product for coronary and peripheral bypass grafting applications.

13 investors

Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings. The company serves healthcare systems and clinicians with diagnostic instruments and solutions.

12 investors

Ateios develops electrode manufacturing techniques designed to accelerate production speed, reduce carbon emissions, and decrease the physical footprint of battery manufacturing and gigafactories. The company provides advanced battery, materials, and software solutions to battery manufacturers.

12 investors

Gilead discovers, develops, and delivers innovative therapeutics for people with life-threatening diseases, focusing on virology, oncology, and inflammation across more than 35 countries. The company combines scientific rigor with global partnerships and licensing programs to expand access to medicines worldwide.

12 investors

DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening. The test offers an alternative to low-dose CT imaging for patients meeting USPSTF criteria and is made available to health systems, primary care providers, and lung screening programs.

12 investors

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds. Its pipeline includes a Phase 2-ready asset and multiple preclinical programs targeting brain health and neuroplasticity.

12 investors

Diligent Robotics develops AI-powered robot assistants for healthcare settings, focusing on mobile manipulation and social intelligence to help hospital staff with routine non-patient-facing tasks. The company's flagship product, Moxi, enables clinical staff to dedicate more time to direct patient care.

12 investors

Genalyte develops Merlin, a real-time diagnostic system that performs laboratory testing directly in clinical settings and integrates results with electronic health records. The company serves healthcare providers including primary care clinics, hospitals, surgery centers, and military facilities.

12 investors

Medable provides a cloud-based platform for clinical research that uses AI and digital tools to accelerate the development of therapies by improving the quality, reach, and efficiency of clinical trials. The platform serves pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites.

12 investors

Odyssey Therapeutics develops small molecule and protein therapeutics targeting upstream signaling nodes and innate immune system mechanisms to prevent pathological inflammation. Its pipeline focuses on autoimmune and inflammatory diseases with large patient populations and unmet medical need.

12 investors

Helicons develops a peptide-based therapeutic platform designed to target intracellular proteins previously considered undruggable by combining the specificity of antibodies with the cell-penetrating properties of small molecules. The platform uses AI and simulation to engineer helical peptides with non-canonical amino acids for precision binding across a range of therapeutic applications.

12 investors

Redcliffe Labs is a diagnostic services company offering doctor-curated health checkup packages, genetic and pathology testing, along with expert consultation, AI assistance, and personalized health guidance. It serves patients across India with accessible, affordable diagnostics, including a women-centric platform.

12 investors

Sana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.

12 investors

Scan.com operates a national imaging network connecting payers, providers, and patients with accredited diagnostic imaging centers, offering transparent scheduling, pricing, and digital report delivery. The platform serves workers' compensation payers, self-funded employers, health plans, referring physicians, and health technology platforms to reduce imaging delays, costs, and improve care outcomes.

12 investors

Sorcero develops AI-powered intelligence solutions for the life sciences industry, helping companies accelerate patient access to therapies and improve medical research and communications. The platform uses medically-tuned large language models to support pharmaceutical, biotech, and healthcare organizations.

12 investors